Eli Lilly and CompanyLLY

Is LLY cheap right now? Every multiple below is scored against its own 10-year range, not a sector average.

$1,137.75+22.50 (+2.02%)24:00 UTC
NYSEHealthcare

Company snapshot

Market Cap
$1T
Mega-cap
+1092%
2016 — today
10-Year Price
+1372%
2016 — today
52-Week Range
$714.59$1,280.34
Current $1,137.75· 75%

Eli Lilly (est. 1876) researches, develops, and markets human pharmaceuticals globally. Its diabetes portfolio includes Basaglar, the Humalog and Humulin lines, Jardiance, Trajenta, and Trulicity. Oncology offerings feature Alimta, Cyramza, Erbitux, Retevmo, Tyvyt, and Verzenio. Autoimmune treatments include Olumiant and Taltz. Neurology/pain products include Cymbalta, Emgality, and Zyprexa. Other key assets include Cialis and Forteo. The firm maintains strategic partnerships with Incyte, Boehringer Ingelheim, and others.

Similar companies

Healthcare companies of comparable size to LLY
CompanyP/EDiv yield
JNJJohnson & Johnson30.32.0%
ABBVAbbVie Inc.73.72.6%
MRKMerck & Co., Inc.115.92.3%
UNHUnitedHealth Group Incorporated24.72.9%
NVSNovartis AG21.03.4%
AZNAstraZeneca PLC24.62.0%
TMOThermo Fisher Scientific Inc.33.00.3%
AMGNAmgen Inc.23.72.6%

Healthcare companies of comparable size — each one shown against its own 10-year range, not a sector average. Browse all stocks we cover.

Valuation in context

P/E ratio
38.2
Below average
Below the 10-year average
Sector median 25.0above sector
P/B ratio
30.0
Below average
Below the 10-year average
Sector median 2.5above sector
EV / EBITDA
30.2
Around average
Around the 10-year average
Sector median 15.4above sector
Dividend Yield
0.6%
Near historic low
Near historic low — last 10 years
Sector median 1.9%below sector
PEG ratio
1.1
Historically cheap
Historically cheap relative to the last 10 years
Sector median 1.5below sector
FCF Yield
2.0%
Around average
Around the 10-year average
Sector median -10.1%above sector
Free · No credit card needed

Get alerted when LLY is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.